
1513883-39-0 Deuterated ruxolitinib
Non pwodwi: ruxolitinib deuterated
CAS: 1513883-39-0
MF: C17H18N6
MW: 306.37
Einecs:
MDL Non.:
Pwopriyete
Aparans blan nan poud blan-blan
Aplikasyon:
Itilizasyon prensipal deuruxolitinib se pou trete alopesi areata. Kòm yon Jak1 ak Jak2 kinaz inibitè, deuruxolitinib efektivman bloke pwosesis la enflamatwa kondwi pa Jak pa vize chemen an siyal Jak-Stat, kidonk jere alopesi Areata, yon maladi auto-immunes defi
Sinonim:
Deuruxolitinib
CTP -543
(3r) -3- (2,2,3,3,4,4,5, 5- octadeuteriocyclopentyl) -3- [4- (7 H-pyrolo [2, 3- d] pyrimidin -4- yl) pyrazol -1- yl] propanenitrile
1H-pirazole -1- propanenitrile, .Beta .- (cyclopentyl -2, 2,3,3,4,4,5, 5- d8) -4- (7h-pirrolo (2, 3- d) Pyrimidin -4- yl)-,,.
1513883-39-0
Deuruxolitinib-d8
(3r) -3- (2,2,3,3,4,4,5, 5- D8) Cyclopentyl -3- (4- (7h-pirrol o (2, 3- d) Pyrimidin -4- yl) -1 hpyrazol -1- yl) propanenitrile
Baj popilè: 1513883-39-0 Deuterated ruxolitinib, Lachin 1513883-39-0 Deuterated ruxolitinib manifaktirè, Swèd

